Watanabe Todd — SEC insider filings

SEC reporting owner CIK 1801061. 68 insider filings on record with FilingPulse; latest filed 2026-11-17.

Transaction summary — filings shown

Covers the 50 most recent of 68 filings on record, filed 2021-12-10 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Arcutis Biotherapeutics, Inc. (ARQT)See Remarks, Director503 legs · 7,501 sh · $30,58462 legs · 417,435 sh · $8,345,38842

Insider filings — Watanabe Todd

FiledFormIssuerReported transactionsSource
2026-11-174Arcutis Biotherapeutics, Inc. (ARQT)Gift (G): 144,232 @ $0EDGAR
2026-11-044Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 4,377 @ $31.86EDGAR
2026-08-054Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 4,375 @ $26.12EDGAR
2026-05-064Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 3,172 @ $23.61EDGAR
2026-03-034Arcutis Biotherapeutics, Inc. (ARQT)Grant/award (A): 102,000 @ $0 · Sale (S): 36,281 @ $25.16 · Sale (S): 1,068 @ $25.91 · Grant/award (A): 266,000 (derivative) @ $0EDGAR
2026-02-044Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 19,833 @ $25.50EDGAR
2025-11-244Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 1,055 @ $30 · Sale (S): 48,945 @ $30.36EDGAR
2025-11-054Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 11,478 @ $24.71 · Sale (S): 69 @ $25.40EDGAR
2025-10-304Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 40,000 @ $25.03EDGAR
2025-10-034Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 15,000 @ $18.91 · Sale (S): 9,261 @ $20.02 · Sale (S): 20,739 @ $20.04EDGAR
2025-09-104Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 9,625 @ $17.54 · Sale (S): 504 @ $17.52EDGAR
2025-08-054Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 11,547 @ $14.33EDGAR
2025-06-124Arcutis Biotherapeutics, Inc. (ARQT)Gift (G): 997 @ $0 · Gift (G): 997 @ $0 · Gift (G): 997 @ $0 · Gift (G): 997 @ $0EDGAR
2025-05-054Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 11,448 @ $15.19EDGAR
2025-03-264Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 1,500 @ $17.52 · Sale (S): 2,171 @ $17.56EDGAR
2025-03-204Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 1,200 @ $17.61EDGAR
2025-03-044Arcutis Biotherapeutics, Inc. (ARQT)Grant/award (A): 151,000 @ $0 · Sale (S): 20,880 @ $13.03 · Sale (S): 4,135 @ $13.28 · Grant/award (A): 396,000 (derivative) @ $0EDGAR
2025-02-044Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 19,301 @ $12.70EDGAR
2024-12-234Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 15,000 @ $15.17EDGAR
2024-12-034Arcutis Biotherapeutics, Inc. (ARQT)Purchase (P): 4,000 @ $1.69 · Purchase (P): 2,038 @ $7.11EDGAR
2024-11-054Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 13,871 @ $8.68EDGAR
2024-08-054Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 14,487 @ $9.02EDGAR
2024-05-034Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 13,783 @ $8.74EDGAR
2024-03-064Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 14,903 @ $11.12EDGAR
2024-03-014Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 2,465 @ $10.60EDGAR
2024-02-154Arcutis Biotherapeutics, Inc. (ARQT)Grant/award (A): 21,666 · Grant/award (A): 33,066 · Grant/award (A): 94,050 · Grant/award (A): 116,100 · Disposition to issuer (D): 65,000 (derivative) · Disposition to issuer (D): 99,200 (derivative) · +2 moreEDGAR
2024-01-174Arcutis Biotherapeutics, Inc. (ARQT)Grant/award (A): 125,000 @ $0 · Grant/award (A): 410,000 (derivative) @ $0EDGAR
2023-12-224Arcutis Biotherapeutics, Inc. (ARQT)Gift (G): 6,563 @ $0 · Gift (G): 6,563 @ $0 · Gift (G): 6,563 @ $0 · Gift (G): 6,563 @ $0EDGAR
2023-12-014Arcutis Biotherapeutics, Inc. (ARQT)Option exercise (M): 59,525 @ $1.68 · Purchase (P): 1,463 @ $6.38 · Option exercise (M): 59,525 (derivative) @ $0EDGAR
2023-03-314/AArcutis Biotherapeutics, Inc. (ARQT)Grant/award (A): 87,500 @ $0 · Grant/award (A): 232,000 (derivative) @ $0EDGAR
2023-03-084Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 2,435 @ $15.26EDGAR
2023-03-024Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 2,343 @ $16.17 · Sale (S): 5,403 @ $15.82 · Sale (S): 69 @ $16.52EDGAR
2023-02-154Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 441 @ $17 · Sale (S): 42 @ $17.01 · Sale (S): 417 @ $17.02 · Sale (S): 100 @ $17.03EDGAR
2023-02-034Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 618 @ $17.00 · Sale (S): 382 @ $17EDGAR
2022-12-094Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 1,000 @ $17.06EDGAR
2022-11-094Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 1,000 @ $18.00EDGAR
2022-10-114Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 1,000 @ $19.51EDGAR
2022-09-094Arcutis Biotherapeutics, Inc. (ARQT)Gift (G): 268,964 @ $0 · Sale (S): 1,000 @ $21.51EDGAR
2022-08-094Arcutis Biotherapeutics, Inc. (ARQT)Option exercise (M): 2,500 @ $1.68 · Sale (S): 2,500 @ $24.74 · Option exercise (M): 2,500 (derivative) @ $0EDGAR
2022-07-124Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 1,500 @ $25 · Sale (S): 4,913 @ $25.41 · Option exercise (M): 7,087 @ $1.68 · Sale (S): 7,087 @ $25.41 · Option exercise (M): 7,087 (derivative) @ $0EDGAR
2022-07-074Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 1,000 @ $22.07EDGAR
2022-06-064Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 1,000 @ $21.06EDGAR
2022-05-054Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 1,000 @ $21.76EDGAR
2022-04-054Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 1,000 @ $21.43EDGAR
2022-03-114Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 300 @ $17EDGAR
2022-03-074Arcutis Biotherapeutics, Inc. (ARQT)Grant/award (A): 70,900 @ $0 · Sale (S): 2,489 @ $16.86 · Sale (S): 70 @ $16.44 · Option exercise (M): 700 @ $1.68 · Sale (S): 700 @ $17.11 · Grant/award (A): 188,100 (derivative) @ $0 · +1 moreEDGAR
2022-03-034Arcutis Biotherapeutics, Inc. (ARQT)Sale (S): 2,153 @ $17.75EDGAR
2022-02-114Arcutis Biotherapeutics, Inc. (ARQT)Option exercise (M): 1,000 @ $1.68 · Sale (S): 1,000 @ $17 · Option exercise (M): 1,000 (derivative) @ $0EDGAR
2022-01-074Arcutis Biotherapeutics, Inc. (ARQT)Option exercise (M): 1,000 @ $1.68 · Sale (S): 300 @ $22.40 · Sale (S): 100 @ $22.06 · Sale (S): 600 @ $21.11 · Option exercise (M): 1,000 (derivative) @ $0EDGAR
2021-12-104Arcutis Biotherapeutics, Inc. (ARQT)Option exercise (M): 1,000 @ $1.68 · Sale (S): 1,000 @ $17 · Option exercise (M): 1,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1801061 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs